健保連海外医療保障 No.131Press: London.5） Department of Health. The Medicines（Pharmacies）（Responsible Pharmacist）Regulations 2008: Guidance. 2009〈https://webarchive.nationalarchives.gov.uk/ukgwa/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_095569.pdf〉6） General Pharmaceutical Council. Standards for the initial education and training of pharmacists. 2021〈https://www.pharmacyregulation.org/sites/default/files/document/standards-for-the-initial-education-and-training-of-pharmacists-january-2021_0.pdf〉7） Miller, G.E., The assessment of clinical skills/competence/performance. Academic Medicine, 1990. 65（9）: p. S63-7.8） General Pharmaceutical Council. Revalidation framework. 2018〈https://www.pharmacyregulation.org/sites/default/files/document/gphc_revalidation_framework_january_2018.pdf〉9） General Pharmaceutical Council. Standards for pharmacy professionals. 2017〈https://www.pharmacyregulation.org/sites/default/files/standards_for_pharmacy_professionals_may_2017_0.pdf〉10） General Pharmaceutical Council. Survey of registered pharmacy professionals 2019: Main Report. 2019〈https://www.pharmacyregulation.org/sites/default/files/document/gphc-2019-survey-pharmacy-professionals-main-report-2019.pdf〉11） Crown, J. Review of Prescribing, Supply ＆ Administration of Medicines - Final Report. 1999〈https://webarchive.nationalarchives.gov.uk/ukgwa/20130105143320/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4077153.pdf〉12） Department of Health. The NHS Plan - a plan for investment, a plan for reform. 2000〈https://webarchive.nationalarchives.gov.uk/ukgwa/20130107105354/http://www.dh.gov.53uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_118522.pdf〉13） Department of Health. Groundbreaking new consultation aims to extend prescribing powers for pharmacists and nurses. 2002 ［cited 2022 30 December］〈https://webarchive.nationalarchives.gov.uk/ukgwa/20051012062254/http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en？CONTENT_ID■4013114＆chk■JkprtS〉14） Scheduleとは薬物の製造・濫用を規制するための物質の法的区分である。5つの区分があり、Schedule1にはLSDなどの治療上の用途がない物質、Schedule2には強力な麻薬、覚醒剤など、Schedule3にはSchedule2よりも濫用の可能性が低い（害が少ない）麻薬・向精神薬、覚醒剤原料など、Schedule4にはベンゾジアゼピン系向精神薬、蛋白同化ステロイドなど、Schedule5には弱オピオイドやコデインが含まれている。15） Medicines ＆ Healthcare Products Regulatory Agency, Consultation on proposals to introduce independent prescribing by pharmacists. 2005: London.16） Commission, P.C.W. The future of primary care: Creating teams for tomorrow. 2015〈https://napc.co.uk/wp-content/uploads/2017/09/Future_of_primary_care.pdf〉17） Department of Health. Choosing health； making healthy choices easier. 2004〈https://webarchive.nationalarchives.gov.uk/ukgwa/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_133489.pdf〉18） Health Education England. Advancing pharmacy education and trianing: a review. 2019〈https://www.hee.nhs.uk/sites/default/files/documents/Advancing％20Pharmacy％20Education％20and％20Training％20Review.pdf〉19） Department of Health. Pharmacy in England: Building on strengths - delivering the future. 2008 ［cited 2014 8 Jan］〈http://
元のページ ../index.html#56